Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Motorcyclist Killed in Crash on Interstate 680 at El Pintado Road


Victim Hit by Vehicle in Fatal Danville Accident

Danville, CA (March 29, 2020) – A motorcyclist was killed in a crash in Danville. The fatal accident occurred on the evening of March 29 on Interstate 680.

A motorcycle rider laid his Honda CBR motorcycle down in the northbound lanes of Interstate 680, near El Pintado Road. He was then hit by another vehicle. The rider died at the accident scene. The driver remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Danville

#94526


December 11, 2019

Pedestrian Killed in Crash on Laguna Niguel Street

Tow Truck Hit Victim in Fatal Laguna Niguel Accident...


October 31, 2019

Man Injured in Crash at East Palm Canyon and Allen Drives

Bicyclist Hit by Car in Cathedral City Accident...


February 6, 2020

Woman Killed in Crash on Interstate 15 Near Temescal Canyon Road

Victim Hit by Car in Fatal Temescal Valley Accident ...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.